TW200621314A - Methods and formulations for making pharmaceutical compositions containing bupropion - Google Patents

Methods and formulations for making pharmaceutical compositions containing bupropion

Info

Publication number
TW200621314A
TW200621314A TW094139004A TW94139004A TW200621314A TW 200621314 A TW200621314 A TW 200621314A TW 094139004 A TW094139004 A TW 094139004A TW 94139004 A TW94139004 A TW 94139004A TW 200621314 A TW200621314 A TW 200621314A
Authority
TW
Taiwan
Prior art keywords
coating
methods
formulations
pharmaceutical compositions
compositions containing
Prior art date
Application number
TW094139004A
Other languages
English (en)
Other versions
TWI377957B (en
Inventor
San-Laung Chow
David Wong
Damian Garcia
Original Assignee
Biokey Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biokey Inc filed Critical Biokey Inc
Publication of TW200621314A publication Critical patent/TW200621314A/zh
Application granted granted Critical
Publication of TWI377957B publication Critical patent/TWI377957B/zh

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW94139004A 2004-11-08 2005-11-07 Methods and formulations for making pharmaceutical compositions containing bupropion TWI377957B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62631704P 2004-11-08 2004-11-08

Publications (2)

Publication Number Publication Date
TW200621314A true TW200621314A (en) 2006-07-01
TWI377957B TWI377957B (en) 2012-12-01

Family

ID=38783436

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94139004A TWI377957B (en) 2004-11-08 2005-11-07 Methods and formulations for making pharmaceutical compositions containing bupropion

Country Status (2)

Country Link
CN (1) CN101052382A (zh)
TW (1) TWI377957B (zh)

Also Published As

Publication number Publication date
TWI377957B (en) 2012-12-01
CN101052382A (zh) 2007-10-10

Similar Documents

Publication Publication Date Title
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
MX2007000008A (es) Formas farmaceuticas orales, protegidas frente al abuso, que contienen (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil) fenol.
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
WO2004108162A3 (en) Controlled release pharmaceutical composition
UA90858C2 (ru) Композиция с контролируемым высвобождением варденафила
WO2001085257A3 (en) Opioid antagonist compositions and dosage forms
MY143795A (en) Tetrahydropyridoindole derivatives
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
WO2007048219A3 (en) Sustained drug release composition
IL179718A0 (en) Pharmaceutical composition containing irbesartan
EE03471B1 (et) Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
WO2010103544A3 (en) A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
TW200630364A (en) 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200607508A (en) Powder formulations for inhalation, comprising enantiomerically pure beta agonists
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
SE9901573D0 (sv) New compounds
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
WO2006115770A3 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
TNSN07013A1 (en) Anti-histaminic composition
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
HUP0204202A2 (hu) Ibuprofent tartalmazó hatóanyag-preparátum, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees